{"transactions":[{"id":3081908,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":147789,"kind":"organization","name":"ACC International Holdings Ltd.","position":1,"cik":"0001521843","reported_name":"ACC International Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2020-07-16T21:05:22.000Z","date":"2020-07-16","kind":"sale","acquired":false,"shares":7823,"price":13.4668,"value":105350.7764,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $13.46 to $13.4684, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":67053,"source":{"system":"sec-edgar","filing":"0001104659-20-084119","document":"tm2024939d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920084119/tm2024939d1_4.xml","form_type":"4"}},{"id":3081907,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":147789,"kind":"organization","name":"ACC International Holdings Ltd.","position":1,"cik":"0001521843","reported_name":"ACC International Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2020-07-16T21:05:22.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":18430,"price":13.1153,"value":241714.979,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.1 to $13.15, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":74876,"source":{"system":"sec-edgar","filing":"0001104659-20-084119","document":"tm2024939d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920084119/tm2024939d1_4.xml","form_type":"4"}},{"id":3081906,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":147789,"kind":"organization","name":"ACC International Holdings Ltd.","position":1,"cik":"0001521843","reported_name":"ACC International Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2020-07-16T21:05:22.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":40000,"price":13.5238,"value":540952.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.338 to $13.61, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":93306,"source":{"system":"sec-edgar","filing":"0001104659-20-084119","document":"tm2024939d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920084119/tm2024939d1_4.xml","form_type":"4"}},{"id":3081905,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":147789,"kind":"organization","name":"ACC International Holdings Ltd.","position":1,"cik":"0001521843","reported_name":"ACC International Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2020-07-16T21:05:22.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":2000,"price":13.35,"value":26700.0,"ownership":{"direct":true},"balance_after":133306,"source":{"system":"sec-edgar","filing":"0001104659-20-084119","document":"tm2024939d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920084119/tm2024939d1_4.xml","form_type":"4"}},{"id":3081904,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":147789,"kind":"organization","name":"ACC International Holdings Ltd.","position":1,"cik":"0001521843","reported_name":"ACC International Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Common Stock","published_at":"2020-07-16T21:05:22.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":3500,"price":13.1253,"value":45938.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.0816 to $13.1581, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":135306,"source":{"system":"sec-edgar","filing":"0001104659-20-084119","document":"tm2024939d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920084119/tm2024939d1_4.xml","form_type":"4"}}]}